Landauer

Glenwood, United States Founded: 1954 • Age: 72 yrs Listed Acquired By Fortive
Radiation monitoring and protection

About Landauer

Landauer is a company based in Glenwood (United States) founded in 1954 was acquired by Fortive in September 2017. Landauer has completed 1 acquisition, including IZI Medical Products. Landauer offers products and services including Luxel+ radiation badges, Occupational Dosimetry, and Medical Dosimetry. Landauer operates in a competitive market with competitors including Comecer, Mirion, G-Con Manufacturing, NuAire and Biomoneta, among others.

  • Headquarter Glenwood, United States
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website landauer.com
  • Social LinkedIn
  • Acquired by Fortive (Sep 2017)
  • Legal Name Landauer Inc
Key Metrics
  • Annual Revenue
    $149.24 M (USD)
    -1
    as on Sep 30, 2016
  • Net Profit
    $18.45 M (USD)
    23
    as on Sep 30, 2016
  • EBITDA
    $26.64 M (USD)
    12
    as on Sep 30, 2016
  • Latest Funding Round
    $42.07K (USD), Grant

    May 2016

  • Investors
    Fortive

    & 1 more

  • Investments & Acquisitions
  • Acquired by
    Fortive

    (Sep 2017)

Products & Services of Landauer

Landauer offers a comprehensive portfolio of products and services, including Luxel+ radiation badges, Occupational Dosimetry, and Medical Dosimetry.

Luxel+ radiation badges
Radiation Monitoring

Devices for tracking radiation exposure in occupational settings.

Occupational Dosimetry
Safety Services

Periodic monitoring of radiation doses for worker protection.

Medical Dosimetry
Medical Technology

Secondary dose verification for medical imaging and treatments.

Funding Insights of Landauer

  • Total Rounds 1
  • Last Round Grant β€” $42,071
  • First Round $42,071

    (May 2016)

  • Investors Count 1

All 1 funding rounds of Landauer with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2016$42,071Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Landauer

Landauer has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Fortive and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Industrial conglomerate with subsidiaries in sensing and automation is operated.
2016fortive.comPortland, United States
Premium access

Investor details for Landauer

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Landauer

5 people are tracked at Landauer (4 in leadership, 1 in team).

NameRoleGroup
David Rancourt
Senior Commercial DirectorLeadership
Emilia Rondolf
CEOLeadership
Ana Sijercic
Sales Director AustralasiaLeadership
Shawn Pickett
Director Of Radiation Safety Support ServicesLeadership
Edna Johnson
Global Events Marketing ManagerTeam
Premium access

Complete people profiles for Landauer

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Landauer

Landauer has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include IZI Medical Products.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Medical consumable accessories for radiology and surgery are manufactured.
izimed.comOwings Mills, United States1993Nov 2011$93M
Premium access

Complete acquisition details for Landauer

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Landauer

5 dated milestones of Landauer across 63 years, from founding to its latest funding, stage changes and deals.

  1. Founded Landauer is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires IZI Medical Products.
  4. Funding First funding round of $42K.
  5. Exit Acquired by Fortive.

Competitors of Landauer

Landauer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Comecer, Mirion, G-Con Manufacturing, NuAire and Biomoneta, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
comecer.com1974Castel Bolognese, Italy$10.57M4
Protective equipment and containment systems for nuclear medicine, nuclear power plants and aseptic manufacturing
mirion.com2006San Francisco, United States–74
Radiation detection, measurement, analysis, and monitoring products are supplied.
gconbio.com2009College Station, United States$13M43
Builds and installs prefabricated, autonomous cleanrooms
nuaire.com1971Plymouth, United Kingdom–265
Laboratory safety equipment is manufactured for research and industrial use.
biomoneta.com2014Bengaluru, India$756,605–
Pathogenic microbes are extracted and killed by developed devices.
noroitlabo.com2006Bouaye, France$496,282–
Developer of protective equipment against biological risks for research, pharma and hospital sectors
helapet.co.uk1984Houghton Regis, United Kingdom––
Medical and cleanroom consumables are manufactured for various applications.
virustatic.com2009Stockport, United Kingdom–1
Anti-viral technology for face masks is developed by Virustatic.
chitozanhealth.com2018Jacksonville, United States$354,100–
Antimicrobial devices and finishes are manufactured for infection control.
Premium access

Detailed competitors of Landauer

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Landauer

The website of Landauer (landauer.com) receives about 36.8K visits a month.

  • Monthly visits
    36.8K
Similar websites

Websites whose visitors overlap most with Landauer. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
instadose.com
100%
–#1,170,426View details
flukebiomedical.com
99%
–#700,084View details
landauer-fr.com
landauer-fr.com
99%
–#3,319,819–
technicalprospects.com
94%
––View details
sunnuclear.com
92%
21.1K#1,127,107View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 23 similar websites and full traffic analytics for Landauer

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 23 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to Landauer

10 companies that operate in the same segment as Landauer (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Landauer

Landauer was founded in 1954 and raised its 1st funding round 62 years after it was founded.

Landauer is headquartered in Glenwood, United States.

Annual revenue of Landauer is $149.24M as on Sep 30, 2016.

Landauer was founded in 1954 and is headquartered in Glenwood, United States. Operations focus on the radiation safety sector, where integrated products for occupational monitoring are developed. Dosimetry services utilize proprietary Optically Stimulated Luminescence (OSL) technology to measure and protect against radiation exposure. These solutions are provided to various industries requiring compliance and safety protocols.

Landauer's top competitors include Mirion, G-Con Manufacturing and Comecer.

Landauer offers Luxel+ radiation badges, Occupational Dosimetry, and Medical Dosimetry.

Landauer has made 1 acquisition, including IZI Medical Products.

Landauer has 2 investors. Key investors include Fortive, and European Union.

Landauer operates through Landauer Inc.

Yes. Landauer was acquired by Fortive in September 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available